A K Judd1, D J Tuttle, R W Jones
1SynVax Inc., 1770 N. Research Park Way, North Logan, UT 84341, USA. synvax@aol.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers developed novel high-affinity ligands for the Nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP). These modified peptides are crucial for understanding N/OFQ system functions, including analgesia.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: